Skip to main content
. Author manuscript; available in PMC: 2014 Aug 15.
Published in final edited form as: Cancer. 2013 May 21;119(16):2999–3006. doi: 10.1002/cncr.28151

Tabe 4.

IMDC risk group criteria for OS in nccRCC

Univariate analysis Multivariable model*
Parameter HR (95% CI) p-value HR (95% CI) p-value
Hb low (<LLN) 1.72(1.23,2.40) 0.002 1.48(1.03,2.14) 0.034
Neutrophilia (>ULN) 3.23(2.24,4.65) <.0001 2.43(1.58,3.74) <.0001
KPS <80 3.15(2.23,4.45) <.0001 2.02(1.35,3.02) 0.0006
Thrombophilia (>ULN) 2.56(1.80,3.63) <.0001 1.13(0.72,1.79) 0.592
Hypercalcaemia (>ULN) 2.13(1.24,3.65) 0.006 1.42(0.78,2.60) 0.256
Dx to treatment initiation <1year 1.53(1.12,2.07) 0.007 1.22(0.87,1.71) 0.251

Abbreviations: Hb= hemoglobin, KPS= Karnofski performance status, Dx= diagnosis, ULN= upper limit of normal, LLN= lower limit of normal

*

c-index of 0.70 (95% CI: 0.66-0.74),